ORIGINAL ARTICLES
Soluble CD14 as a predictor of subsequent development of recurrent wheezing in hospitalized young children with respiratory syncytial virus–induced bronchiolitis

https://doi.org/10.1016/S1081-1206(10)61762-0Get rights and content

Background

Respiratory syncytial virus (RSV) infection in infancy that causes severe bronchiolitis had been implicated as potentially responsible for the subsequent development of asthma. The CD14 receptor responds to the microbial burden in the environment and modulates the development of the allergic phenotype.

Objective

To investigate the relationship between the serum level of soluble CD14 (sCD14) in children hospitalized because of RSV-induced bronchiolitis and the subsequent development of recurrent wheezing.

Methods

Serum levels of sCD14 were measured in 21 children younger than 14 months who were hospitalized because of RSV-induced bronchiolitis. The diagnosis of significant wheezing was evaluated by recurrent episodes of coughing, wheezing, and respiratory distress, which were relieved by inhalation of β-agonists and corticosteroids.

Results

Of the 21 children, 19 were followed up for 12 months. The mean sCD14 serum level of 14,521 ± 1,773 pg/mL in the group of 6 children who did not exhibit recurrent wheezing was significantly higher than the level of 11,243 ± 3,264 pg/mL in the group of 13 children who exhibited significant recurrent wheezing (P < .05). The subsequent development of recurrent wheezing was not influenced by positive family history of asthma, number of siblings, sex, or breast-feeding.

Conclusion

A follow-up period of 12 months in this small pilot group showed that high serum levels of sCD14 modulate the influence of RSV on subsequent recurrent episodes of wheezing.

REFERENCES (35)

  • PG Holt et al.

    Interactions between respiratory tract infections and atopy in the aetiology of asthma

    Eur Respir J

    (2002)
  • N Sigurs et al.

    Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7

    Am J Respir Crit Care Med

    (2000)
  • A Cauwels et al.

    The origin and function of soluble CD14 in experimental bacterial meningitis

    J Immunol

    (1999)
  • D Vercelli et al.

    CD14: a bridge between innate immunity to adaptive IgE responses

    J Endotoxin Res

    (2001)
  • FD Martinez et al.

    Role of microbial burden in aetiology of allergy and asthma

    Lancet

    (1999)
  • FD Martinez

    Viruses and atopic sensitization in the first years of life

    Am J Respir Crit Care Med

    (2000)
  • CR Pullan et al.

    Wheezing, asthma and pulmonary dysfunction 10 years after infection with respiratory syncytial virus

    BMJ

    (1982)
  • Cited by (8)

    • A systematic review of predictive modeling for bronchiolitis

      2014, International Journal of Medical Informatics
      Citation Excerpt :

      This helps avoid under-treatment with a risk of complications, such as permanent impairment of lung function, as well as over-treatment with potentially harmful medicines, such as steroids in transient early wheezers [196]. For bronchiolitis patients, various predictors of recurrent wheezing and emerging asthma have been identified in the research literature [171,180,197,202,204,206–233]. Using clinical variables assessed at age 2, Mikalsen et al. [205] built a logistic regression model to predict asthma diagnosis at age 11.

    View all citing articles on Scopus
    View full text